This transcript was observed in TCGA breast cancer cohort to be expressed at very low levels (median 0 RSEM value, range 0-255) compared with the predominant transcript, variant 4 (median 59.9 RSEM value, range 0-1390) and therefore may not truly reflect total LRH-1 expression in breast cancers. Here, NR5A2 is linked to breast carcinoma.